Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

High-speed imaging tracks live brain cell activity in awake mice

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

Study highlights AI limits in heart care

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

New material may outperform current agents used in medical imaging

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

Imaging technique maps the brain's nerve fiber labyrinth with micrometer precision

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

New brain atlas offers unprecedented detail in MRI scans

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Holographic optogenetics could enable faster brain mapping for new discoveries

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

Todays Updates

NeuroVoices: Robert Alexander, MD, on the Evolution of Antiamyloid Therapeutics in Alzheimer Disease Robert Alexander, MD, Isabella Ciccone, MPH

At CTAD 2025, the chief scientific officer at the Banner Alzheimer’s Institute discussed emerging antiamyloid therapies, clinical trial insights, and treatment duration in Alzheimer disease.

Neflamapimod Reduces Plasma GFAP in Dementia With Lewy Bodies, Showing Correlation With Clinical Improvement Marco Meglio

New data highlights neflamapimod's potential in reducing biomarkers and improving clinical outcomes for dementia with Lewy bodies, paving the way for Phase 3 trials.

CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease Marco Meglio

Semaglutide shows no significant impact on Alzheimer disease progression in large trials, despite some biomarker improvements and consistent safety profiles.

New Clarity AD Analysis Reveal How Lecanemab Engages and Clears Neurotoxic Protofibrils in Alzheimer Disease Isabella Ciccone, MPH

In a study presented at CTAD 2025, patients treated with lecanemab showed a 59% increase in cerebrospinal fluid protofibril concentration at 12 months and a 45% increase at 18 months.

Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease Marco Meglio

A groundbreaking phase 1 trial reveals promising results for a new stem cell therapy targeting Alzheimer disease, advancing to phase 2 studies.

PROTECT: Sparsentan Offers CV Protection Benefits as First-Line Therapy in IgAN Chee Kay Cheung, MBChB, PhD

Recurrent UTIs Linked to QOL Burden in Kidney Transplant Recipients

Recurrent UTIs Linked to QOL Burden in Kidney Transplant Recipients

Todays Updates

NeuroVoices: Robert Alexander, MD, on the Evolution of Antiamyloid Therapeutics in Alzheimer Disease Robert Alexander, MD, Isabella Ciccone, MPH

At CTAD 2025, the chief scientific officer at the Banner Alzheimer’s Institute discussed emerging antiamyloid therapies, clinical trial insights, and treatment duration in Alzheimer disease.

Neflamapimod Reduces Plasma GFAP in Dementia With Lewy Bodies, Showing Correlation With Clinical Improvement Marco Meglio

New data highlights neflamapimod's potential in reducing biomarkers and improving clinical outcomes for dementia with Lewy bodies, paving the way for Phase 3 trials.

CTAD Presentation Lays Insights Into Disappointing Phase 3 EVOKE Trial of GLP-1 Semaglutide in Alzheimer Disease Marco Meglio

Semaglutide shows no significant impact on Alzheimer disease progression in large trials, despite some biomarker improvements and consistent safety profiles.

New Clarity AD Analysis Reveal How Lecanemab Engages and Clears Neurotoxic Protofibrils in Alzheimer Disease Isabella Ciccone, MPH

In a study presented at CTAD 2025, patients treated with lecanemab showed a 59% increase in cerebrospinal fluid protofibril concentration at 12 months and a 45% increase at 18 months.

Autologous Stem Cell Approach Shows Promising Early Phase 1 Data in Alzheimer Disease Marco Meglio

A groundbreaking phase 1 trial reveals promising results for a new stem cell therapy targeting Alzheimer disease, advancing to phase 2 studies.

PROTECT: Sparsentan Offers CV Protection Benefits as First-Line Therapy in IgAN Chee Kay Cheung, MBChB, PhD

Recurrent UTIs Linked to QOL Burden in Kidney Transplant Recipients

Recurrent UTIs Linked to QOL Burden in Kidney Transplant Recipients

Latest News

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a breakthrough in brain imaging by developing the world's first technology to capture high-resolution ...

There are limits in applying AI to images of the heart, according to a new study from the Smidt Heart Institute at Cedars-Sinai published in the Journal of the American Society of Echocardiography.

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally ...

In order to understand brain diseases, neuroscientists try to untangle the intricate nerve fiber labyrinth of our brain. Before analyzing brain tissue under a microscope, it is often soaked in paraffin wax to achieve high-quality ...

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging.

Recent technological advances have opened new possibilities for neuroscience research, allowing researchers to map the brain's structure and synaptic connectivity (i.e., the junctions via which neurons communicate with each ...

News All Time

Guidelines developed for postmastectomy radiation therapy

In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).

Adding molecular breast imaging to digital breast tomosynthesis beneficial for dense breasts

For women with dense breasts, the addition of molecular breast imaging (MBI) as a supplement to digital breast tomosynthesis (DBT) increases overall and invasive cancer detection, according to a study published online Sept. ...

CT scanners secretly waste more energy than used by a typical household, but there's a fix

Medical imaging is one of the biggest contributors of a hospital's energy use. Magnetic resonance imaging (MRI) and computed tomography (CT) are particularly carbon intensive, partly due to their need to be constantly cooled. ...

Mammograms may benefit women well into their 80s, study finds

For many older women, the question of whether to continue breast cancer screening has been uncertain. While most guidelines recommend mammograms up to age 74, advice for women 75 and older has been less clear. Now, a new ...

Turning off idling CT scanner saves 140kWh per week, enough to power an Australian home year round

CT scanners are usually left running 24/7 to be ready for patients who need emergency scans. Now researchers have conducted the first Australian study on the benefits of switching off radiology equipment when not in use.

2016 to 2023 saw decline in U.S. pediatric radiologists

The number of U.S. pediatric radiologists declined from 2016 to 2023, according to a study published online Sept. 9 in the Journal of the American College of Radiology.

Innovative imaging techniques show what happens inside bones during hip replacement surgery

Uncemented hip replacement surgery uses implants with roughened surfaces designed to allow the patient's bone to grow directly onto the implant, creating a strong, natural biological bond. Unlike cemented implants, which ...

AI effective at detecting advanced breast cancer, but misses some cases

A Korean research team has reported that artificial intelligence (AI) used in mammography missed 14% of invasive breast cancers, the type where delayed diagnosis can directly impact patient survival.

Reversible technique turns mouse scalps transparent for imaging brain development

During childhood and adolescence, our brain goes through a lot of changes. But studying those changes in juvenile mice is challenging because scientists don't have a way to repeatedly image the same animal's neural pathways ...

Dual-mode tracer could enable surgeons to see and 'hear' prostate cancer

A preclinical evaluation of a new "dual-mode" tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but also provide them with much more consistent and targeted guidance during ...

Imaging provides indicators for early detection of depression, paths for future prevention and treatment efforts

Novel imaging research indicates that young adults with a higher genetic risk for depression showed less brain activity in several areas when responding to rewards and punishments. The study also uncovered notable differences ...

Jul 25 2025 This Week in Cardiology

The VENTOUX study of endurance athletes, the 10,000 step myth was not busted, rate vs rhythm control for AF, and GLP1 drugs and observational studies are the topics John Mandrola, MD, discusses in this week’s podcast.

Large-scale neuroimaging data collection proves feasible in low-income communities

People are diverse, and the environments they live in may influence them differently. This broad diversity increases the need for neuroimaging studies that collect data from large communities.

S2 Episode 2: The Exercise Prescription for MS Just Got Stronger

Join Drs Anne Cross and Rob Motl as they discuss how new data and clinical insights are reshaping how exercise helps people with MS.

Body Composition Analysis in HF: Time to Replace BMI?

A recent meta-analysis prompts consideration of measurements of visceral and subcutaneous adiposity to better estimate cardiovascular risk than BMI.

AI helps radiologists spot more lesions in mammograms

Artificial intelligence (AI) improves breast cancer detection accuracy for radiologists when reading screening mammograms, helping them devote more of their attention to suspicious areas, according to a study published in ...

Recommended News For You

Telemedicine services linked to reducing excess mortality

Prostate cancer relapse after radiotherapy is strongly predicted by biological markers.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke

Study finds primary-care doctors often overlook prostate cancer risk in Black men

Recommended Articles For You

Exploring the Normal Range of Monocytes: A Comprehensive Guide 

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide 

Unveiling the Secrets of Early Cancer: Emerging Strategies to Decipher Its Biology 

Unraveling the Genetic Mystery of Hereditary Spherocytosis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

2.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?

3.

Life quality after childhood cancer is quantifiable thanks to outcome indicators.

4.

Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state

5.

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

1.

Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence

2.

CAR T-Cell Therapy: Revolutionizing Hematologic Malignancies

3.

Understanding the Importance of CA125: A Comprehensive Guide 

4.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

5.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

2.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion

3.

Efficient Management of First line ALK-rearranged NSCLC - Part III

4.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot